Jiannan Yao

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Fluorescent Probe

Transforming Growth Factor

Metastatic Colorectal Cancer

Top Venues

Cancer immunology, immunotherapy : CII

Journal of oncology

Technology in cancer research & treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Wenjing Zhao, Ziwei Liang, Yongshi Yao, Yang Ge, Guangyu An, Ling Duan, Jiannan Yao
GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration. Cancer immunology, immunotherapy : CII 73 (7) (2024)
Wenjing Zhao, Ziwei Liang, Yongshi Yao, Yang Ge, Guangyu An, Ling Duan, Jiannan Yao
GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration. Cancer immunology, immunotherapy : CII 73 (7) (2024)
Wenjing Zhao, Ziwei Liang, Yongshi Yao, Yang Ge, Guangyu An, Ling Duan, Jiannan Yao
GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration. Cancer immunology, immunotherapy : CII 73 (7) (2024)
Wenjing Zhao, Ziwei Liang, Yongshi Yao, Yang Ge, Guangyu An, Ling Duan, Jiannan Yao
GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration. Cancer immunology, immunotherapy : CII 73 (7) (2024)
Wenjing Zhao, Ziwei Liang, Yongshi Yao, Yang Ge, Guangyu An, Ling Duan, Jiannan Yao
GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration. Cancer immunology, immunotherapy : CII 73 (7) (2024)
Wenjing Zhao, Ziwei Liang, Yongshi Yao, Yang Ge, Guangyu An, Ling Duan, Jiannan Yao
GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration. Cancer immunology, immunotherapy : CII 73 (7) (2024)
Ziwei Liang, Enyu Zhang, Ling Duan, Nathaniel Weygant, Guangyu An, Bin Hu, Jiannan Yao
Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma. Technology in cancer research & treatment 21 (2022)
Ling Ding, Yuning Yang, Yang Ge, Qin Lu, Zixing Yan, Xuzheng Chen, Jian Du, Sassan Hafizi, Xiaohui Xu, Jiannan Yao, Jian Liu, Zhiyun Cao, Nathaniel Weygant
Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity. Cancers 13 (22) (2021)
Heshu Liu, Tao Wen, Ying Zhou, Xiaona Fan, Tan Du, Tianbo Gao, Lina Li, Jian Liu, Lei Yang, Jiannan Yao, Yang Ge, Guangyu An
DCLK1 Plays a Metastatic-Promoting Role in Human Breast Cancer Cells. BioMed research international 2019 (2019)
Dongfeng Qu, Nathaniel Weygant, Jiannan Yao, Parthasarathy Chandrakesan, William L Berry, Randal May, Kamille Pitts, Sanam Husain, Stan Lightfoot, Min Li, Timothy C Wang, Guang Yu An, Cynthia Clendenin, Ben Z Stanger, Courtney W Houchen
Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cancer. Journal of oncology 2019 (2019)
Jiannan Yao, Wanchun Zang, Yang Ge, Nathaniel Weygant, Pan Yu, Lei Li, Guanhua Rao, Zhi Jiang, Rui Yan, Linjia He, Yang Yu, Mulan Jin, Gang Cheng, Guang Yu An
RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients. Canadian journal of gastroenterology & hepatology 2018 (2018)